Authors

• Alicia Rodríguez-Pla (ORCID: https://orcid.org/0000-0002-6255-5306)
• Robert Spiera (ORCID: https://orcid.org/0000-0003-2911-6800)
• Leland W.K. Chung (ORCID: https://orcid.org/0000-0003-0072-6939)
• Marcin A. Trojanowski (ORCID: https://orcid.org/0000-0003-2583-1591)
• Hélène Goulaouic (ORCID: https://orcid.org/0009-0003-4713-0216)
• Tamiko R. Katsumoto (ORCID: https://orcid.org/0000-0002-7978-0315)
• Souheil El‐Chemaly (ORCID: https://orcid.org/0000-0003-2929-5589)
• Virginia Steen (ORCID: https://orcid.org/0000-0002-6333-0133)
• Melanie Espinasse
• Daniel E. Furst (ORCID: https://orcid.org/0000-0001-7857-2373)
• Robyn T. Domsic (ORCID: https://orcid.org/0000-0002-2765-0922)
• Richard M. Silver (ORCID: https://orcid.org/0000-0002-2038-3278)
• Flavia V. Castelino
• Hong Wang (ORCID: https://orcid.org/0000-0002-4879-4482)
• Rui Wang (ORCID: https://orcid.org/0009-0000-1622-2802)

Institutions

• Boston University (US)
• University of Southern California (US)
• Hospital for Special Surgery (US)
• Medical University of South Carolina (US)
• University of Pittsburgh (US)
• Georgetown University (US)
• VA Palo Alto Health Care System (US)
• Sanofi (France) (FR)
• AVEO Oncology (United States) (US)
• Massachusetts General Hospital (US)
• Sanofi (United States) (US)
• Mayo Clinic in Arizona (US)
• Stanford Medicine (US)
• Scleroderma Foundation (US)
• Stanford University (US)

Publication Details

Journal

Lara D. Veeken

Published

2025-03-14

DOI

https://doi.org/10.1093/rheumatology/keaf062

Citations

3

Primary Topic

Systemic Sclerosis and Related Diseases

Type

article

Field-Weighted Citation Impact

4.41